SecBot SecBot
SECBOTREPLAY Home › Report › LMAT

LMAT · LeMaitre Vascular (LMAT) reported strong Q4 2025 results with revenue…

LEMAITRE VASCULAR INC · 8-K filed Feb 25, 2026 at 16:54 ET

At the news

BULLISHIMPACT 8/10

8-K filed Feb 25, 2026 at 16:54 ET

LeMaitre Vascular (LMAT) reported strong Q4 2025 results with revenue of $64.5 million (+16% YoY) and diluted EPS of $0.68 (+39% YoY), driven by international growth and margin expansion. The company raised its quarterly dividend by 25% to $0.25/share and authorized a $100 million share repurchase program. Full-year 2026 guidance calls for $280 million in sales (+12%) and operating income of $77.8 million (+21% adjusted), signaling continued profitability growth.

  • Q4 2025 revenue: $64.5 million (+16% YoY, +15% organic)
  • Q4 2025 diluted EPS: $0.68 (+39% YoY)
  • Gross margin expanded 240 bps to 71.7%
  • Operating income: $18.8 million (+47% YoY)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access